Home › Companies › CARIBOU BIOSCIENCES INC. › 2023-2024
At CARIBOU BIOSCIENCES INC.'s shareholder meeting held June 13, 2024, in the 2023-2024 proxy season, 54 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 581 separate fund positions. On the most widely held item on that ballot — Ratification of the appointment of Deloitte & Touche LLP as the Company's independent… — CARIBOU BIOSCIENCES INC.'s filing reports the proposal as approved, with 99.6% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: CARIBOU BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 14, 2024.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and CARIBOU BIOSCIENCES INC.’s Form 8-K, filed June 14, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 13, 2024: 4 items on CARIBOU BIOSCIENCES INC.’s Form 8-K, filed June 14, 2024: 3 elected · 1 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024
Explore CARIBOU BIOSCIENCES INC. in the interactive database Compare manager voting policies
These tallies are CARIBOU BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 14, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Rachel Haurwitz, Ph.D. | 57,375,324 | -- | -- | 2,287,189 | 13,621,407 | 96% | Elected | — |
| Elect Director: Dara Richardson-Heron, M.D. | 50,232,080 | -- | -- | 9,430,433 | 13,621,407 | 84% | Elected | — |
| Elect Director: Natalie Sacks, M.D | 50,173,915 | -- | -- | 9,488,598 | 13,621,407 | 84% | Elected | — |
| 2. Ratification of Selection of Independent Registered Public Accounting Firm | 73,021,434 | 231,293 | 31,193 | -- | -- | 99.6% | Approved | — |
Source: CARIBOU BIOSCIENCES INC., Form 8-K, filed with the SEC on June 14, 2024 — read the filing on EDGAR.
Each item below shows how the 54 asset managers that disclosed a CARIBOU BIOSCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Description as filed by funds: Election of three Class III directors to serve until the Company's 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified or until their earlier death, resignation or removal. The three nominees for election are: Dara Richardson-Heron, M.D.
CARIBOU BIOSCIENCES INC.’s own tally for this item (“Elect Director: Dara Richardson-Heron, M.D.”): 50,232,080 for, 9,430,433 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 - Election of Three Class III Directors Each of the following nominees was elected to serve as a Class III director, to hold office until the Company's 2027 annual meeting of stockholders and until their respective successor is duly elected and qualified or until their earlier death, res…”
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 14,122,294 for, 3,439,279 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 4,283,426 | 0 | 0 | 61,389 | For |
| Vanguard | 4,055,125 | 0 | 0 | 0 | For |
| BlackRock | 2,173,727 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 1,702,065 | Withhold |
| Fidelity | 1,369,489 | 0 | 0 | 0 | For |
| Charles Schwab | 825,282 | 0 | 0 | 0 | For |
| Advantage Advisers Xanthus Fund, L.L.C. | 0 | 0 | 0 | 392,210 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 367,824 | Withhold |
| Royce | 266,890 | 0 | 0 | 0 | For |
| TIAA | 266,467 | 0 | 0 | 0 | For |
| Equitable | 144,491 | 0 | 0 | 104,520 | Mixed |
| BRUCE FUND INC | 200,000 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 0 | 0 | 181,487 | Withhold |
| Global X | 176,446 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 111,416 | Withhold |
| Lincoln Financial | 63,000 | 0 | 0 | 40,164 | Mixed |
| ProShares | 0 | 0 | 0 | 97,745 | Withhold |
| RMB INVESTORS TRUST | 0 | 0 | 0 | 80,990 | Withhold |
| TARGET PORTFOLIO TRUST | 70,100 | 0 | 0 | 0 | For |
| ETF Series Solutions | 0 | 0 | 0 | 53,549 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 40,985 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 37,538 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 34,118 | 0 | 0 | 0 | For |
| Pacific Life | 33,655 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 31,154 | Withhold |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Description as filed by funds: Election of three Class III directors to serve until the Company's 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified or until their earlier death, resignation or removal. The three nominees for election are: Natalie Sacks, M.D.
CARIBOU BIOSCIENCES INC.’s own tally for this item (“Elect Director: Natalie Sacks, M.D”): 50,173,915 for, 9,488,598 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 - Election of Three Class III Directors Each of the following nominees was elected to serve as a Class III director, to hold office until the Company's 2027 annual meeting of stockholders and until their respective successor is duly elected and qualified or until their earlier death, res…”
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 14,089,654 for, 3,471,919 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 4,283,426 | 0 | 0 | 61,389 | For |
| Vanguard | 4,055,125 | 0 | 0 | 0 | For |
| BlackRock | 2,173,727 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 1,702,065 | Withhold |
| Fidelity | 1,369,489 | 0 | 0 | 0 | For |
| Charles Schwab | 825,282 | 0 | 0 | 0 | For |
| Advantage Advisers Xanthus Fund, L.L.C. | 0 | 0 | 0 | 392,210 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 367,824 | Withhold |
| Royce | 266,890 | 0 | 0 | 0 | For |
| TIAA | 266,467 | 0 | 0 | 0 | For |
| Equitable | 144,491 | 0 | 0 | 104,520 | Mixed |
| BRUCE FUND INC | 200,000 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 0 | 0 | 181,487 | Withhold |
| Global X | 176,446 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 111,416 | Withhold |
| Lincoln Financial | 63,000 | 0 | 0 | 40,164 | Mixed |
| ProShares | 0 | 0 | 0 | 97,745 | Withhold |
| RMB INVESTORS TRUST | 0 | 0 | 0 | 80,990 | Withhold |
| TARGET PORTFOLIO TRUST | 70,100 | 0 | 0 | 0 | For |
| ETF Series Solutions | 0 | 0 | 0 | 53,549 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 40,985 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 37,538 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 34,118 | 0 | 0 | 0 | For |
| Pacific Life | 33,655 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 31,154 | Withhold |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of three Class III directors to serve until the Company's 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified or until their earlier death, resignation or removal. The three nominees for election are: Rachel Haurwitz, Ph.D.
CARIBOU BIOSCIENCES INC.’s own tally for this item (“Elect Director: Rachel Haurwitz, Ph.D.”): 57,375,324 for, 2,287,189 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 - Election of Three Class III Directors Each of the following nominees was elected to serve as a Class III director, to hold office until the Company's 2027 annual meeting of stockholders and until their respective successor is duly elected and qualified or until their earlier death, res…”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 15,837,782 for, 1,723,791 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 4,344,815 | 0 | 0 | 0 | For |
| Vanguard | 4,055,125 | 0 | 0 | 0 | For |
| BlackRock | 2,173,727 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 1,702,065 | Withhold |
| Fidelity | 1,369,489 | 0 | 0 | 0 | For |
| Charles Schwab | 825,282 | 0 | 0 | 0 | For |
| Advantage Advisers Xanthus Fund, L.L.C. | 392,210 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 367,824 | 0 | 0 | 0 | For |
| Royce | 266,890 | 0 | 0 | 0 | For |
| TIAA | 266,467 | 0 | 0 | 0 | For |
| Equitable | 249,011 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 200,000 | 0 | 0 | 0 | For |
| Aberdeen | 181,487 | 0 | 0 | 0 | For |
| Global X | 176,446 | 0 | 0 | 0 | For |
| American Century | 111,416 | 0 | 0 | 0 | For |
| Lincoln Financial | 99,429 | 0 | 0 | 3,735 | For |
| ProShares | 97,745 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 80,990 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 70,100 | 0 | 0 | 0 | For |
| ETF Series Solutions | 53,549 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 40,985 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,538 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 34,118 | 0 | 0 | 0 | For |
| Pacific Life | 33,655 | 0 | 0 | 0 | For |
| John Hancock | 31,154 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.6% Approved · of votes cast
Description as filed by funds: Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024
CARIBOU BIOSCIENCES INC.’s own tally for this item (“2. Ratification of Selection of Independent Registered Public Accounting Firm”): 73,021,434 for, 231,293 against — passed, per its Form 8-K filed June 14, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 - Ratification of Selection of Independent Registered Public Accounting Firm The stockholders ratified the selection by the Audit Committee of the Company's Board of Directors of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year endi…”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 17,661,959 for, 7,208 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 4,337,607 | 7,208 | 0 | 0 | For |
| Vanguard | 4,055,125 | 0 | 0 | 0 | For |
| BlackRock | 2,173,727 | 0 | 0 | 0 | For |
| Dimensional | 1,702,065 | 0 | 0 | 0 | For |
| Fidelity | 1,369,489 | 0 | 0 | 0 | For |
| Charles Schwab | 825,282 | 0 | 0 | 0 | For |
| Advantage Advisers Xanthus Fund, L.L.C. | 392,210 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 367,824 | 0 | 0 | 0 | For |
| Royce | 266,890 | 0 | 0 | 0 | For |
| TIAA | 266,467 | 0 | 0 | 0 | For |
| Equitable | 249,011 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 200,000 | 0 | 0 | 0 | For |
| Aberdeen | 181,487 | 0 | 0 | 0 | For |
| Global X | 176,446 | 0 | 0 | 0 | For |
| American Century | 111,416 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 107,594 | 0 | 0 | 0 | For |
| Lincoln Financial | 103,164 | 0 | 0 | 0 | For |
| ProShares | 97,745 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 80,990 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 70,100 | 0 | 0 | 0 | For |
| ETF Series Solutions | 53,549 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 40,985 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,538 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 34,118 | 0 | 0 | 0 | For |
| Pacific Life | 33,655 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 90,317,771 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | State Street | 4.81% |
| 2 | Vanguard | 4.49% |
| 3 | BlackRock | 2.41% |
| 4 | Dimensional | 1.88% |
| 5 | Fidelity | 1.52% |
| 6 | Charles Schwab | 0.91% |
| 7 | Advantage Advisers Xanthus Fund, L.L.C. | 0.43% |
| 8 | Direxion Shares ETF Trust | 0.41% |
| 9 | Royce | 0.30% |
| 10 | TIAA | 0.30% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| PFM Health Sciences, LP and affiliates | 7.18% | DEF14A |
| Avidity Partners Management LP and affiliates | 7.04% | DEF14A |
| S | 7.04% | 13G |
| State Street | 7.03% | 13F |
| Rachel E. Haurwitz | 5.22% | 13D |
| Pfizer Inc. | 5.19% | DEF14A |
| Vanguard Group | 4.68% | 13F |
| Rachel Haurwitz, Ph.D. | 4.60% | DEF14A |
| Point72 | 3.97% | 13F |
| Dimensional Fund Advisors | 2.31% | 13F |
Percentages above are of 90,317,771 shares outstanding, as reported by CARIBOU BIOSCIENCES INC. on its Form 10-Q dated May 2, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CARIBOU BIOSCIENCES INC.’s 10-Q dated May 2, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
CARIBOU BIOSCIENCES INC. proxy season coverage: 2023-2024 (this page).
proxyvotesnow.com, “CARIBOU BIOSCIENCES (CRBU) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/caribou-biosciences-inc/2024 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.